- Tytuł:
- Pharmacokinetics and coagulation biomarkers in children and adults with hemophilia A receiving emicizumab prophylaxis every 1, 2, or 4 weeks
- Autorzy:
- Źródło:
- In Research and Practice in Thrombosis and Haemostasis January 2024 8(1)
Czasopismo naukowe